We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · July 14, 2015

Potential Diagnostic Biomarker for Parkinson's Disease

Movement Disorders: Official Journal of the Movement Disorder Society

 

Additional Info

Disclosure statements are available on the authors' profiles:

Movement Disorders: Official Journal of the Movement Disorder Society
Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
Mov. Disord. 2015 Jun 01;30(7)945-952, G Castellanos, MA Fernández-Seara, O Lorenzo-Betancor, S Ortega-Cubero, M Puigvert, J Uranga, M Vidorreta, J Irigoyen, E Lorenzo, A Muñoz-Barrutia, C Ortiz-de-Solorzano, P Pastor, MA Pastor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading